Introduction
Clinically, cardiac malignant tumours are extremely rare and primary cardiac lymphomas (PCL) account for 1-2% of cardiac malignant tumours therein [1, 2]. Cardiac lymphomas can provoke a wide spectrum of symptoms, including symptoms of arrhythmia, heart failure, embolism, dyspnea and fatigue [2-4]. These multiple clinical manifestations of cardiac lymphomas may depend on the tumor location, pattern of growth, histologic type, and invasive features, which also lead to misdiagnosis. Like other malignancies, most cardiac malignant tumours are associated with a poor outcome, but patients with cardiac lymphoma have a better prognosis if they are treated timely and appropriately [3].